Abstract
Background: Exposure and response prevention (ERP) is a form of cognitive behavioral therapy (CBT) that can effectively relieve obsessive-compulsive symptoms and tic symptoms in patients with obsessive-compulsive disorder (OCD) and Tourette syndrome (TS). However, the effect size of ERP is still unclear. Methods: In this study, we performed a meta-analysis to identify the efficacy of ERP for individuals with OCD and TS. The standard mean difference (SMD) with a 95% confidence interval (CI) was calculated to assess the effect size of the efficacy for ERP. We used subgroup and meta-regression analysis to explore the heterogeneity of the pooled SMD of ERP for OCD. Results: A total of 17 studies including a total of 926 patients with OCD and 66 patients with TS were identified. We observed a small-to-medium effect size of ERP for both OCD (SMD = -0.21, 95% CI: -0.47 to 0.06) and TS (SMD = -0.26, 95% CI: -0.75 to 0.22). Conclusions: In conclusion, we found that ERP is effective for patients with OCD and TS. We suggest a combination with other therapies and the development of online ERP services that might prove a promising new direction for healthcare providers.
Introduction
Obsessive-Compulsive Disorder (OCD) and Tourette Syndrome (TS) are chronic psychiatric conditions that frequently co-occur. Clinical data suggests that between 30% and 60% of individuals diagnosed with one of these disorders may also exhibit symptoms of the other. Exposure and Response Prevention (ERP), a specialized form of cognitive-behavioral therapy (CBT), has long been considered the "gold standard" for treating OCD. In ERP, patients are systematically exposed to triggers that provoke obsessions or premonitory urges but are coached to refrain from performing their usual rituals or tics.
Despite its widespread clinical use, the precise statistical effect size of ERP across both OCD and TS has remained somewhat unclear. Furthermore, while ERP is well-established for OCD, its role in treating TS is less frequently quantified compared to other behavioral interventions like Habit Reversal Training (HRT). This meta-analysis aims to quantify the efficacy of ERP for these conditions and explore whether demographic factors like age or gender influence treatment outcomes.
Methods
The researchers conducted a systematic meta-analysis in accordance with PRISMA guidelines, aggregating data from 17 peer-reviewed clinical trials published through November 2019. The study population included 926 patients with OCD and 66 patients with TS. Efficacy was quantified using the Standard Mean Difference (SMD) with a 95% confidence interval (CI).
To account for potential variations between study designs and populations, a random-effects model was employed. The researchers also investigated heterogeneity using $I^2$ statistics and meta-regression, specifically looking at variables such as publication year, mean age, and gender distribution. A critical component of the methodology was the quality assessment of the included studies. Each trial was evaluated using a modified Jadad scale, which assesses factors like randomization, blinding, and the description of withdrawals to ensure the robustness of the pooled data.
Results
The meta-analysis revealed a small-to-medium effect size for ERP in both patient groups. For OCD, the pooled SMD was -0.21 (95% CI: -0.47 to 0.06). For TS, the pooled SMD was -0.26 (95% CI: -0.75 to 0.22). While the confidence intervals for both groups crossed zero, the authors interpreted these results as indicative of a consistent therapeutic benefit, aligning with the effects seen in other established behavioral interventions.
Significant heterogeneity was observed among the OCD studies ($I^2 = 71.2\%$), suggesting that treatment outcomes varied considerably across different trials. In contrast, the TS studies showed 0% heterogeneity, though the authors cautioned that this might be an artifact of the very small sample size, as only two studies met the inclusion criteria for TS. Meta-regression analysis indicated that age, gender, and publication year did not significantly influence the treatment's success, suggesting that ERP's mechanism of action is relatively stable across these demographics.
Discussion
The finding that ERP is effective for both OCD and TS lends weight to the "common circuitry" hypothesis. This theory suggests that these disorders share a common pathophysiological foundation, likely involving abnormal functioning within the cortical-basal ganglia-thalamo-cortical circuitry. By targeting the behavioral response to intrusive thoughts or physical urges, ERP may help recalibrate these neural pathways through habituation.
Furthermore, the study highlights that ERP's effect size is comparable to that of common pharmacological treatments, such as Selective Serotonin Reuptake Inhibitors (SSRIs). Notably, ERP may offer a tolerability advantage; the meta-analysis noted a lower average dropout rate for ERP (approximately 10%) compared to medication (approximately 17%). For patients with TS, ERP appears to help by increasing the threshold for "premonitory urges"—the uncomfortable physical sensations that precede a tic—allowing patients to endure the distress without resorting to the tic behavior.
Conclusion
This meta-analysis confirms that Exposure and Response Prevention is an effective intervention for individuals suffering from OCD and TS. However, the high heterogeneity in OCD results and the limited data for TS highlight the need for further research. The authors suggest that the future of ERP may lie in expanding accessibility through online delivery platforms and investigating combination therapies for patients who do not respond to behavioral treatment alone. Long-term follow-up studies are also necessary to determine the durability of ERP's therapeutic effects over years rather than months.
Summary updated